Revenue and Profit - Revenue for Q3 2024 was CNY 127,592,555.68, an increase of 10.25% compared to the same period last year[3] - Net profit attributable to shareholders was CNY -2,918,513.95, a decrease of 134.41% year-on-year[3] - Net profit excluding non-recurring items was CNY -3,586,108.82, down 167.97% from the previous year[3] - Total operating revenue for the current period is CNY 428,499,956.45, a decrease of 17% compared to CNY 516,164,255.38 in the previous period[15] - Net profit for the current period is CNY 13,588,305.39, a significant decrease of 80% from CNY 68,556,581.24 in the previous period[16] - Basic earnings per share for the current period is CNY 0.13, down from CNY 0.62 in the previous period[17] Assets and Liabilities - Total assets at the end of Q3 2024 were CNY 1,646,791,447.69, a decrease of 2.18% from the end of the previous year[3] - The company’s total equity attributable to shareholders was CNY 1,335,706,335.24, a slight decrease of 0.59% from the previous year[3] - The total current assets decreased from ¥978,386,486.11 to ¥757,240,486.53, reflecting a reduction of about 22.6%[12] - The total non-current assets increased from ¥705,127,186.28 to ¥889,550,961.16, indicating a growth of approximately 26.1%[13] - The total liabilities decreased from ¥307,154,263.63 to ¥278,284,341.10, showing a decline of about 9.4%[13] - The total assets decreased from ¥1,683,513,672.39 to ¥1,646,791,447.69, reflecting a reduction of approximately 2.2%[13] Cash Flow - Cash flow from operating activities was CNY -117,338,044.31, a decline of 172.94% compared to the same period last year[3] - The company reported a significant decrease in net cash flow from operating activities, primarily due to lower revenue and delayed payments from major customers[8] - Cash flow from operating activities shows a net outflow of CNY -117,338,044.31, compared to a net inflow of CNY 160,876,172.24 in the previous period[18] - The net cash flow from investment activities was 118,159,050.68 CNY, compared to a negative cash flow of 86,731,880.10 CNY in the previous period[19] - The net cash flow from financing activities was -16,839,952.43 CNY, improving from -36,533,184.26 CNY in the previous period[19] - The net increase in cash and cash equivalents was -15,140,543.06 CNY, contrasting with an increase of 39,285,580.39 CNY in the previous period[19] Expenses and Investments - Research and development expenses decreased by 33.36% to CNY 14,374,762.66 for the first nine months of 2024[8] - Investment income increased by 292.38% to CNY 1,201,763.33 for the first nine months of 2024[8] - Research and development expenses for the current period are CNY 14,374,762.66, down from CNY 21,569,337.80 in the previous period, indicating a reduction of approximately 33%[15] - The company reported a financial expense of CNY -8,923,220.22, significantly improved from CNY -20,366,499.21 in the previous period[15] Shareholder Information - The total number of common shareholders at the end of the reporting period is 7,965[9] - The company has a total of 57,000,000 shares held by Liansheng Chemical Group, accounting for 52.78% of the total shares[10] - The company has a total of 10,000,000 shares held by Mu Jianyu, representing 9.26% of the total shares[10] Other Financial Information - The company received government subsidies amounting to CNY 80,799.46 in Q3 2024[4] - Cash and cash equivalents at the end of the period totaled 151,152,291.47 CNY, down from 289,948,271.82 CNY at the beginning of the period[19] - The cash inflow from investment activities is CNY 676,367,093.27, a substantial increase compared to CNY 118,200,199.87 in the previous period[18] - The cash outflow for dividend payments and interest was 21,448,345.85 CNY, down from 41,245,341.65 CNY in the previous period[19] - The impact of exchange rate changes on cash and cash equivalents was 878,403.00 CNY, compared to 1,674,472.51 CNY in the previous period[19] - The third quarter report was not audited[19]

Financial Performance - The company's operating revenue for the first half of 2024 was CNY 300,907,400.77, a decrease of 24.86% compared to CNY 400,438,176.67 in the same period last year[11]. - Net profit attributable to shareholders was CNY 16,441,315.67, down 72.03% from CNY 58,777,008.71 year-on-year[11]. - Basic earnings per share decreased by 72.22%, from CNY 0.54 to CNY 0.15[11]. - The net cash flow from operating activities was CNY -109,031,087.33, a decline of 262.30% compared to CNY 67,179,091.46 in the previous year[11]. - Total assets at the end of the reporting period were CNY 1,655,193,976.38, down 1.68% from CNY 1,683,513,672.39 at the end of the previous year[11]. - The net assets attributable to shareholders decreased by 0.32%, from CNY 1,343,624,141.08 to CNY 1,339,360,836.31[11]. - The weighted average return on net assets was 1.22%, down 3.18% from 4.40% in the previous year[11]. - In Q2 2024, the company reported operating revenue of CNY 166.36 million, a year-on-year decrease of 0.44% but a quarter-on-quarter increase of 23.64%[30]. - The net profit attributable to shareholders in Q2 2024 was CNY 8.44 million, down 66.22% year-on-year but up 5.48% quarter-on-quarter[30]. Industry Trends - The fine chemical industry is experiencing a slow recovery, with a 5.4% year-on-year increase in revenue and a 3.4% increase in operating profit for the chemical raw materials and products manufacturing sector in the first half of 2024[18]. - The global pharmaceutical market is projected to grow from $13.93 trillion in 2021 to $17.11 trillion by 2025, with a compound annual growth rate (CAGR) of 5.3%[20]. - The global pesticide market expanded from $35.575 billion in 2006 to $87.7 billion in 2022, with a CAGR of approximately 5.80%[20]. - The demand for pesticides is anticipated to remain stable due to the increasing global population and the need for food production efficiency[21]. - The fine chemical industry is crucial for the stability and safety of important supply chains, with a focus on innovation and high-quality development in the upcoming years[18]. Company Strategy and Focus - The company is focused on the development of high-end fine chemicals, which is expected to be a key trend in the industry[18]. - The company is recognized as a top 100 high-tech enterprise in fine chemicals and a national-level "specialized, refined, and innovative" small giant enterprise, with a unique industrial chain technology based on BDO[24]. - The company is focusing on green, low-carbon, and digital transformation, emphasizing the development of fine chemicals, electronic chemicals, and biodegradable new materials[24]. - The company aims to upgrade its BDO industrial chain towards ultra-pure electronic chemicals and biodegradable new materials to strengthen its position in the specialty fine chemicals sector[24]. - The company is actively promoting technological innovation and iteration, continuously launching new products and exploring new applications[30]. Financial Management and Investments - The company has made progress in its fundraising projects, with investment completion rates of 83.81% for ultra-pure electronic chemicals and 30.98% for the 52.6 million tons/year electronic and specialty chemicals renovation project[34]. - The total amount of raised funds is RMB 727.03 million, with a net amount after deducting issuance costs of RMB 727.03 million[53]. - The total amount invested from the raised funds during the reporting period is RMB 86.99 million, with a cumulative investment of RMB 407.31 million[54]. - The company has established long-term stable partnerships with renowned companies such as Bayer Group and Syngenta, enhancing its market position[35]. - The company has authorized the use of up to CNY 390 million of temporarily idle raised funds for cash management, with a usage period not exceeding twelve months[57]. Risk Management - The company faces risks including macroeconomic fluctuations, raw material price volatility, and safety production risks[1]. - Future plans and development strategies are subject to risks and should not be considered as firm commitments to investors[1]. - The company is focused on enhancing its core competitiveness through increased R&D efforts to mitigate risks associated with macroeconomic fluctuations[65]. - The company plans to optimize procurement strategies and expand its supplier base to manage risks related to raw material price volatility[66]. - Safety management measures are being strengthened to prevent accidents involving hazardous chemicals, ensuring compliance with safety regulations[67]. Environmental Compliance - The company is committed to reducing environmental impact by improving waste management and adhering to stricter environmental regulations[68]. - The company has established an emergency response plan for environmental incidents, which has been filed with local environmental authorities[83]. - The company has implemented measures to reduce carbon emissions, including steam waste heat utilization and photovoltaic power generation[84]. - The company has established a dedicated EHS department to oversee environmental management and compliance[81]. - The company has implemented strict monitoring of various pollutants, with all online monitoring indicators meeting compliance standards[78]. Shareholder Information - The total number of shares is 108,000,000, with 75% being limited sale condition shares and 25% being unrestricted sale condition shares[110]. - The largest shareholder, Liansheng Chemical Group Co., Ltd., holds 52.78% of the shares, amounting to 57,000,000 shares[110]. - The company has not implemented any share buyback programs during the reporting period[110]. - The report indicates that there are no significant changes in the shareholding structure during the reporting period[110]. - The company distributed a cash dividend of 1.98 yuan per 10 shares, totaling 21.384 million yuan to shareholders for the fiscal year 2023[86]. Compliance and Governance - The financial statements were approved by the board of directors on August 27, 2024, ensuring compliance with accounting standards[150]. - The company has assessed its ability to continue as a going concern for the next 12 months and found no issues affecting this capability[151]. - The company has not engaged in any significant litigation or arbitration matters during the reporting period, indicating a stable legal standing[94]. - The company has not reported any penalties or rectification situations during the reporting period, reflecting compliance with regulations[95]. - The company has not experienced any non-operating fund occupation by major shareholders or related parties during the reporting period, ensuring financial integrity[93].

第三届监事会第十二次会议决议公告 证券代码：301212 证券简称：联盛化学 公告编号：2024-028 浙江联盛化学股份有限公司 表决结果：同意 3 票、反对 0 票、弃权 0 票。 (二)审议通过了《关于公司<2024 年半年度募集资金存放与使用情况的专项报告> 的议案》 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 浙江联盛化学股份有限公司（以下简称"公司"）第三届监事会第十二次会议（以 下简称"本次会议"）于 2024 年 8 月 27 日在公司会议室以现场结合通讯的方式召开。 会议通知于2024年8月17日通过专人送出、邮件（电子邮件）或传真等方式发出。 本次会议应出席监事 3 名，实际出席监事 3 名，本次会议由监事会主席黄卫国先生 主持，保荐机构代表人员列席了会议。本次会议的召集、召开及表决程序符合《中 华人民共和国公司法》《中华人民共和国证券法》等有关法律、行政法规、规范性 文件、部门规章及《浙江联盛化学股份有限公司章程》的相关规定，会议决议合法、 有效。 二、监事会会议审议情况 经与会监事认真审议，形成如下决议： ( ...

证券代码：301212 证券简称：联盛化学 公告编号：2024-027 浙江联盛化学股份有限公司 第三届董事会第十四次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 浙江联盛化学股份有限公司（以下简称"公司"）第三届董事会第十四次会议（以 下简称"本次会议"）于 2024 年 8 月 27 日在公司会议室以现场的方式召开。会议通知 于 2024 年 8 月 17 日通过专人送出、邮件（电子邮件）或传真等方式发出，会议应 出席董事 8 人，实际出席董事 8 人。本次会议由公司董事长牟建宇女士召集和主持， 公司监事、高级管理人员和保荐机构代表人员列席了会议。本次会议的召集、召开及 表决程序符合《中华人民共和国公司法》《中华人民共和国证券法》等有关法律、行 政法规、规范性文件、部门规章及《浙江联盛化学股份有限公司章程》（以下简称《公 司章程》）的相关规定，会议决议合法、有效。 二、董事会会议审议情况 经与会董事认真审议，形成如下决议： （一）审议通过了《关于公司 <2024 年半年度报告>及其摘要的议案》 董事会认为：公司 20 ...

证券代码：301212 证券简称：联盛化学 公告编号：2024-030 经公司总经理提名，董事会审计委员会、董事会提名委员会审查后，公司于 2024 年 8 月 27 日召开第三届董事会第十四次会议，审议通过了《关于聘任财 务负责人的议案》。同意聘任黄清辉先生为公司财务负责人，任期自本次董事会 审议通过之日起至第三届董事会任期届满之日（2025 年 1 月 23 日）止。黄清 辉先生简历详见附件。 浙江联盛化学股份有限公司 关于变更财务负责人的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、财务负责人辞职情况 浙江联盛化学股份有限公司（以下简称"公司"）董事会于近日收到财务负责 人戴素君女士的书面辞职报告，戴素君女士因已达退休年龄申请辞去财务负责人 职务。戴素君女士作为财务负责人原定任期至公司第三届董事会任期届满之日止， 即 2022 年 1 月 24 日至 2025 年 1 月 23 日。根据《深圳证券交易所上市公司自 律监管指引第 2 号——创业板上市公司规范运作》的相关规定，戴素君女士的辞 职报告自送达董事会之日起生效，离任后公司仍返聘其为顾问 ...

证券代码：301212 证券简称：联盛化学 公告编号：2024-023 浙江联盛化学股份有限公司 【注：根据先进先出的原则，以投资者证券账户为单位计算持股期限，持股 1 个月（含 1 个月）以内，每 10 股补缴税款 0.396000 元；持股 1 个月以上至 1 年（含 1 年）的，每 10 股补缴税款 0.198000 元；持股超过 1 年的，不需补缴税 款。】 2023 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 浙江联盛化学股份有限公司（以下简称"公司"或"本公司"）2023 年年度权 益分派方案已获 2024 年 5 月 16 日召开的 2023 年年度股东大会审议通过，现将 权益分派事宜公告如下： 一、股东大会审议通过权益分派方案情况 1、公司于 2024 年 5 月 16 日召开 2023 年年度股东大会，审议通过了《关于 公司<2023 年度利润分配预案>的议案》，具体方案如下：公司以截至 2024 年 4 月 24 日的总股本 108,000,000 股为基数，向全体股东每 10 股派发现金红利 1.98 元（含税 ...

国浩律师（杭州）事务所 关于 浙江联盛化学股份有限公司 2023 年年度股东大会 法律意见书 地址：杭州市上城区老复兴路白塔公园 B 区 2 号、15 号国浩律师楼 邮编：310008 Grandall Building, No.2＆No.15, Block B, Baita Park, Old Fuxing Road, Hangzhou, Zhejiang 310008, China 电话/Tel: (+86)(571) 8577 5888 传真/Fax: (+86)(571) 8577 5643 电子邮箱/Mail：grandallhz@grandall.com.cn 网址/Website：http://www.grandall.com.cn 二〇二四年五月 国浩律师（杭州）事务所 法律意见书 国浩律师（杭州）事务所 关于浙江联盛化学股份有限公司 2023 年年度股东大会 法律意见书 致：浙江联盛化学股份有限公司 国浩律师（杭州）事务所（以下简称"本所"）接受浙江联盛化学股份有限 公司（以下简称"公司"）委托，指派律师出席公司 2023 年年度股东大会（以下 简称"本次股东大会"），并依据《中华人民共和国 ...

证券代码：301212 证券简称：联盛化学 公告编号：2024-022 浙江联盛化学股份有限公司 2023年年度股东大会决议公告 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 1、召开时间：2024年5月16日（星期四）14:30 2、召开地点：浙江省临海市头门港经济开发区东海第三大道9号公司会议室 3、召开方式：本次股东大会采用现场投票与网络投票表决相结合的方式召开 4、召集人：浙江联盛化学股份有限公司（以下简称"公司"）董事会 5、主持人：董事长牟建宇女士 6、本次会议的召集、召开程序符合《中华人民共和国公司法》《上市公司股东 大会规则》《上市公司治理准则》《深圳证券交易所上市公司股东大会网络投票实施 细则》《深圳证券交易所创业板股票上市规则》等有关法律、行政法规、规范性文件 和《浙江联盛化学股份有限公司章程》《浙江联盛化学股份有限公司股东大会议事规 则》等有关规定。 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 特别提示： 1、本次股东大会不存在否决议案的情形。 二、会议出席情况 （一）股东出席的总体情况 参加本次股东大 ...

浙江联盛化学股份有限公司 监事会议事规则 浙江联盛化学股份有限公司 监事会议事规则 第一条 为进一步规范浙江联盛化学股份有限公司（以下简称公司）监事 会的议事方式和表决程序，促使监事和监事会有效地履行监督职责，完善公司 法人治理结构，根据《中华人民共和国公司法》（以下简称《公司法》）《中 华人民共和国证券法》《深圳证券交易所上市公司自律监管指引第2号——创业 板上市公司规范运作》和《浙江联盛化学股份有限公司章程》（以下简称《公 司章程》）等有关规定，制订本规则。 第二条 公司设监事会，监事会由三名监事组成，其中股东代表监事二名， 由股东大会选举产生；职工代表监事一名，由职工代表大会、职工大会或者其 他形式民主选举产生。 监事会设监事会主席一名，由全体监事过半数选举产生。 第三条 监事会会议分为定期会议和临时会议。 监事会定期会议应当每六个月至少召开一次会议。 监事可以提议召开临时监事会会议。 第四条 在发出召开监事会定期会议的通知之前，监事会主席应当向全体 监事征集会议提案。在征集提案和征求意见时，监事会主席应当说明监事会重 在对公司规范运作和董事、高级管理人员职务行为的监督而非公司经营管理的 决策。 第五条 ...

浙江联盛化学股份有限公司 本人阮涛涛，1985 年出生，中国国籍，无境外永久居留权，本科学历，律师。 2009 年至今历任浙江利群律师事务所实习律师、律师、合伙人；2020 年至今担 任公司独立董事。 （二）独立性说明 2023 年，本人在担任公司独立董事期间，未在公司担任除独立董事以外的任 何职务，也未在公司主要股东公司担任任何职务，与公司以及主要股东之间不存 在妨碍本人进行独立客观判断的关系，不存在影响独立董事独立性的情况，符合 《上市公司独立董事管理办法》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等法律、法规、规范性文件及《公司章程》《独 立董事工作细则》中关于独立董事独立性的相关要求。 二、2023 年度履职情况 （一）本人出席股东大会、董事会的情况 2023 年度独立董事述职报告 （阮涛涛先生） 2023 年度，本人作为浙江联盛化学股份有限公司（以下简称"公司"）的 独立董事，在任职期间本人严格按照《中华人民共和国公司法》（以下简称"《公 司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、《上市 公司独立董事管理办法》等有关法律、法规、规范性文件及《浙江 ...